PYPD PDUFA Date: D-PLEX100 Page updated November 5, 2026 · next FDA decision on the calendar · Data as of Nov 5, 2026 5:03 AM ET FDA decision (PDUFA) target Nov 28, 2026 · PolyPid Ltd. · Prevention of surgical site infections in patients undergoing abdominal colorectal surgery
Key facts FDA PDUFA target date 2026-11-28
Drug / candidate D-PLEX100
Indication Prevention of surgical site infections in patients undergoing abdominal colorectal surgery
Company PolyPid Ltd.
Market-cap tier Micro
New to FDA decisions? Read what a PDUFA date is and how often the FDA approves drugs .
See the full 2026 PDUFA calendar → All November 2026 PDUFA dates → FAQ When is the PYPD PDUFA date? The FDA PDUFA target date for PYPD (PolyPid Ltd.) is 2026-11-28 for D-PLEX100. Dates are company/FDA-sourced and can slip. Verify against primary filings.
What is PYPD's drug D-PLEX100? D-PLEX100 is PolyPid Ltd.'s candidate under FDA review for Prevention of surgical site infections in patients undergoing abdominal colorectal surgery.
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes.